| 000 | 01703 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517235620.0 | ||
| 264 | 0 | _c20210520 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a2405-4569 | ||
| 024 | 7 |
_a10.1016/j.euf.2018.08.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeyton, Charles C | |
| 245 | 0 | 0 |
_aThe Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy. _h[electronic resource] |
| 260 |
_bEuropean urology focus _c01 2020 |
||
| 300 |
_a104-111 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
| 650 | 0 | 4 | _aCytoreduction Surgical Procedures |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aLymphocytes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplastic Cells, Circulating |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 | _aNeutrophils |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aThrombectomy |
| 700 | 1 | _aAbel, E Jason | |
| 700 | 1 | _aChipollini, Juan | |
| 700 | 1 | _aBoulware, David C | |
| 700 | 1 | _aAzizi, Mounsif | |
| 700 | 1 | _aKaram, Jose A | |
| 700 | 1 | _aMargulis, Vitaly | |
| 700 | 1 | _aMaster, Viraj A | |
| 700 | 1 | _aMatin, Surena F | |
| 700 | 1 | _aRaman, Jay D | |
| 700 | 1 | _aSexton, Wade J | |
| 700 | 1 | _aWood, Christopher G | |
| 700 | 1 | _aSpiess, Philippe E | |
| 773 | 0 |
_tEuropean urology focus _gvol. 6 _gno. 1 _gp. 104-111 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.euf.2018.08.023 _zAvailable from publisher's website |
| 999 |
_c28826473 _d28826473 |
||